NCT02569723 2021-03-30
Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy
University of California, Davis
Phase NA Completed
Clinical Trials
11 trialsNCT01295086 2020-11-02
Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer
Odense University Hospital
Phase NA Completed
NCT00846482 2020-09-16
Exploratory Study Of The ERCC-1 Gene
Albert Einstein College of Medicine
Phase NA Completed
NCT03213444 2019-02-15
Impact of Adjuvant Chemotherapy in Patients With Colon Cancer
University of Sao Paulo General Hospital
Phase NA Completed
NCT00448838 2016-12-15
Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
University of Miami
Phase NA Completed
NCT01364376 2016-08-23
Focus
Zhejiang University
Phase NA Completed
NCT00462501 2016-01-20
Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00039611 2013-06-20
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
National Cancer Institute (NCI)
Phase NA Completed
NCT00250029 2011-09-27
Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen
New Mexico Cancer Research Alliance
Phase NA Completed
NCT01366118 2011-06-03
TT
Grupo Hospital de Madrid
Phase NA Completed
NCT00040820 2011-03-07
Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer
Roswell Park Cancer Institute
Phase NA Completed